Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s

There is no “department of cures.”[1][1] There are many diverse players involved in drug development, each of whom brings critical financial, intellectual, and human resources to the process. However, no one is in charge of the overall direction the field takes—charting the course and